Michelle Hill obtained PhD in biochemistry at The University of Queensland, Australia. She currently leads the Precision and Systems Biomedicine Laboratory at QIMR Berghofer Medical Research Institute, Brisbane, Australia, which aims to improve health outcomes by harnessing the power of omics and computational systems biology. Michelle has been leading her team in innovative use of mass spectrometry-based omics technologies, including the development of novel biomarker pipelines and subcellular profiling methods. Application of these methods has enabled discovery of blood biomarkers for early detection of oesophageal adenocarcinoma, and discovery of novel lipid-mediated mechanisms for extracellular vesicle cargo loading.